Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: WMT stock price vs LLY: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at LLY's multiple
Needs LLY P/E.
Implied fair value · at WMT's multiple
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 95% equity / 5% debt · EV / Revenue 1.29x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
WALMART INC. · implied price per share
Bear
$26.01
Base
$31.42
Bull
$38.87
ELI LILLY AND COMPANY · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
TARGET CORP
WMT vs TGT
Costco Wholesale Corporation
WMT vs COST
Amazon.com, Inc.
WMT vs AMZN
CVS Health Corporation
WMT vs CVS
Walgreens Boots Alliance, Inc.
WMT vs WBA
DOLLAR GENERAL CORP
WMT vs DG
Pfizer Inc.
WMT vs PFE
Merck & Co., Inc.
WMT vs MRK
Johnson & Johnson
WMT vs JNJ
AbbVie Inc.
WMT vs ABBV
Amgen Inc.
WMT vs AMGN
Bristol-Myers Squibb Company
WMT vs BMY
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe WMT can maintain stable earnings and modest growth while the market continues to reward it with a premium consumer-staples-like multiple, then adding or holding WMT makes sense because the P/E-based implied price suggests 13.2% upside; if you prioritize growth and margin expansion, LLY remains the stronger operator.
On a P/E basis, WMT's current price of $118.88 sits below the implied price of $134.59, suggesting about 13.2% upside. However, the cross-company comparison is distorted by LLY's much higher growth and margin structure, which justifies a premium multiple.
Supporting Metrics
